Nabriva Therapeutics AG to Provide Development Update and Announce Full Year 2015 Financial Results; Conference Call on Wednesday, ...
VIENNA, Austria and KING OF PRUSSIA, Pa., April 19, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:NBRV) Nabriva Therapeutics AG, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious …